Acute myeloid leukemia stratifies as 2 clinically relevant sphingolipidomic subtypes.

Autor: Paudel BB; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA., Tan SF; Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA., Fox TE; Department of Pharmacology, University of Virginia, Charlottesville, VA., Ung J; Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA.; Department of Microbiology/Immunology/Cancer Biology, University of Virginia, Charlottesville, VA., Golla U; Department of Medicine, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Hershey, PA., Shaw JJP; Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA., Dunton W; Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA., Lee I; Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA.; Department of Internal Medicine, Baylor College of Medicine, Houston, TX., Fares WA; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA., Patel S; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA., Sharma A; Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA.; Penn State Cancer Institute, Hershey, PA., Viny AD; Department of Medicine, Division of Hematology & Oncology, and of Genetics & Development, Herbert Irving Comprehensive Cancer Center, New York, NY.; Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, NY., Barth BM; Department of Chemistry, Biology, and Health Sciences, South Dakota School of Mines and Technology, Rapid City, SD.; Department of Natural Sciences, University of Alaska Southeast, Juneau, AK., Tallman MS; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL., Cabot M; Department of Biochemistry & Molecular Biology, East Carolina University, Greenville, NC.; East Carolina Diabetes and Obesity Institute, Brody School of Medicine, East Carolina University, Greenville, NC., Garrett-Bakelman FE; Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA.; Department of Biochemistry & Molecular Genetics, University of Virginia, Charlottesville, VA.; University of Virginia Cancer Center, Charlottesville, VA., Levine RL; Human Oncology and Pathogenesis Program and Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Kester M; Department of Pharmacology, University of Virginia, Charlottesville, VA., Feith DJ; Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA.; University of Virginia Cancer Center, Charlottesville, VA., Claxton D; Department of Medicine, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Hershey, PA.; Penn State Cancer Institute, Hershey, PA., Janes KA; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA.; Department of Biochemistry & Molecular Genetics, University of Virginia, Charlottesville, VA.; University of Virginia Cancer Center, Charlottesville, VA., Loughran TP Jr; Department of Medicine, Division of Hematology & Oncology, University of Virginia, Charlottesville, VA.; University of Virginia Cancer Center, Charlottesville, VA.
Jazyk: angličtina
Zdroj: Blood advances [Blood Adv] 2024 Mar 12; Vol. 8 (5), pp. 1137-1142.
DOI: 10.1182/bloodadvances.2023010535
Databáze: MEDLINE